Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.
Issue link: http://outpatientsurgery.uberflip.com/i/491203
WE TAKE PAIN PERSONALLY REASON #8 IT'S YOUR FIGHTING SHOT AT SINKING POST OP PAIN. The proven option for e!ectively managing post op pain while reducing narcotic consumption. The ON-Q* Pain Relief System is more than a single shot. It's titratable, which means it's customizable. 1 It maximizes analgesic benefits for up to 120 hours—compared to the 8-24 hours of relief provided by single shots and liposomal bupivacaine. 1-4 ON-Q* is also able to help save hospitals time and money because ON-Q* patients recover more quickly, are able to get back on their feet faster,and start physical therapy sooner than patients given narcotics alone. 1,5-10 FOR MORE INFORMATION CALL 800Ä 448Å3569 OR VISIT FACTVSFICTION.INFO There are inherent risks in all medical devices. Please refer to the product labeling for Indications, Cautions, Warnings, and Contraindications. Failure to follow the product labeling could directly impact patient safety. Physician is responsible for prescribing and administering medications per instructions provided by the drug manufacturer. Refer to www.halyardhealth.com for product safety Technical Bulletins. 1. Data on file. 2. Golf M, Daniels SE, Onel E. A Phase III, randomized, placebo controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther. Sep 2011;28(9):776-788. 3. Gorfine SR, Onel E, Patou G, et al. Bupivacaine Extended-Release Liposome Injection for Prolonged Postsurgical Analgesia in Patients Undergoing Hemorrhoidectomy: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial. Dis Colon Rectum. Dec 2011;54(12):1552-1159. 4. Simone et al. Center for Drug Evaluation and Research, Application number 022496Orig1s000. 2010. 5. White et al. Use of a continuous local anesthetic infusion for pain management after median sternotomy. Anesthesiology. 2003;99:918-23. 6. Dowling et al. Improved pain control after cardiac surgery: Results of a randomized, double-blind, clinical trial. J Thorac Cardiovasc Surg. 2003; 126:1271-8. 7. Forastiere E, et al. E#ectiveness of continuous wound infusion of .5% ropavacaine by ON-Q pain relief system for postoperative pain management after open nephrectomy. Brit J Anaesth. 2008; 101(6): 841-847. 8. Liu et al. E$cacy of continuous wound catheters delivering local anesthetic for postoperative analgesia: a quantitative and qualitative systematic review of randomized controlled trials. J Am Coll Surg. 2006; vol. 203, no. 6, 914-931. 9. Truitt, M. et al, Continuous Intercostal Nerve Blockade for Rib Fractures: Ready for Primetime?, The Journal of Trauma injury, Infection, and Critical Care, Vol. 71, No. 6, Dec. 2011. 10. Beaussier M, El'Ayoubi H, Schi#er E, et al. Continuous preperitoneal infusion of ropavacaine provides e#ective analgesia and accelerated recovery after colorectal surgery. Anesthesiology. 2007; 107(3):461-8. ON-Q* Pain Relief System. *Registered Trademark or Trademark of Halyard Health, Inc. or its a$liates. © 2015 HYH. All rights reserved. RX Only. MK-00751 3/2015. PAIN MANAGEMENT YOU CAN DEPEND ON.